Drug
Hu3f8 With GM Csf
Hu3f8 With GM Csf: highest development phase Phase 1/2, developed by Y-mAbs Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Y-mAbs Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Hu3F8 With GM-CSF NCT01757626 | Phase 1/2 | Neuroblastoma |
Latest
No recent events.
Follow Hu3f8 With GM Csf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.